Following the adverse outcome pathway from micronucleus to cancer using H2B-eGFP transgenic healthy stem cells
Bastian Niklas Hölzel, Kurt Pfannkuche, Bernhard Allner, Hans Thomas Allner, Jürgen Hescheler, Daniel Derichsweiler, Henner Hollert, Andreas Schiwy, Julia Brendt, Michael Schaffeld, Alexander Froschauer & Petra Stahlschmidt-Allner Following the adverse outcome pathway from micronucleus to cancer using H2B-eGFP transgenic healthy stem cells. Arch Toxicol 94, 3265–3280 (2020).
